Roland Magnusson/iStock Editorial via Getty Images

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) said their drug Enhertu met the target for objective response rate (ORR) and showed durable response in multiple HER2-expressing advanced solid tumors in heavily

Source link

You May Also Like

TravelBank Makes American NDC Content Available in Exchanges

TravelBank has launched booking features for American Airlines’ New Distribution Capability content…

Israeli soldiers uncover Gaza tunnel that once held hostages -army By Reuters

3/3 © Reuters. An underground cell which, according to Israel’s military, was…

The latest from the UAW strike

The UAW continues its strike at three auto plants in the Midwest…

California Senate passes bill requiring large companies to report carbon footprint

Justin Sullivan/Getty Images News California legislators passed a first-of-its-kind bill Tuesday that…